Integrating substance abuse care with community diabetes care: implications for research and clinical practice.
about
Performance of the Tobacco, Alcohol, Prescription Medication, and Other Substance Use (TAPS) Tool for Substance Use Screening in Primary Care PatientsSubstance use and mental diagnoses among adults with and without type 2 diabetes: Results from electronic health records dataUsing electronic health record data for substance use Screening, Brief Intervention, and Referral to Treatment among adults with type 2 diabetes: Design of a National Drug Abuse Treatment Clinical Trials Network study.Expanding the National Drug Abuse Treatment Clinical Trials Network to address the management of substance use disorders in general medical settings.Medication-assisted therapy for opioid addiction.Nonpsychiatric medication interventions initiated by a postgraduate year 2 psychiatric pharmacy resident in a patient-centered medical home.High-risk alcohol use and anxiety and depression symptoms in adolescents and adults with type 1 diabetes mellitus: a cross-sectional study.Patients with diabetes respond well to contingency management treatment targeting alcohol and substance use.Challenges and opportunities for integrating preventive substance-use-care services in primary care through the Affordable Care Act.Substance use disorders and psychiatric comorbidity in mid and later life: a review.Substance Use Disorders among Patients with Type 2 Diabetes: a Dangerous but Understudied Combination.Design of the NIDA clinical trials network validation study of tobacco, alcohol, prescription medications, and substance use/misuse (TAPS) tool.Barriers to integrating the continuum of care for opioid and alcohol use disorders in primary care: A qualitative longitudinal study.Both nicotine reward and withdrawal are enhanced in a rodent model of diabetes.Substance use disorders and medical comorbidities among high-need, high-risk patients with diabetes.
P2860
Q30837457-A59C973D-BF60-48D4-A11C-20298E8EFA2FQ30995447-74770397-5BDB-4655-932C-B43A0D2D33F8Q31022565-3DC37DDE-0578-43F0-A774-9B24143284BDQ33968667-5F27A24F-99F6-43DF-909C-5D38F49103CFQ34247772-87193B3E-7F6B-48EC-B491-774D494569ABQ35219850-F4BC2DA2-C849-4765-87DB-5DDA050C4D94Q35225549-2CA5A140-150D-4B82-A883-4126297D8E06Q36342524-AA145611-BF39-44C0-B401-FAB6B45A81D4Q37700093-4AE604F0-ED5E-486B-86F2-838192B81743Q37719528-336E3AFA-F17C-42BB-B506-DFC2BA18CDAEQ39013270-F0FE3181-54F4-429E-879A-F9C4DDC46639Q41174863-69592AD9-041D-4A7C-972A-65D1A5F6E03BQ44350730-CE5D6192-E199-41B4-A5C6-384315025FB7Q50448927-0CAE951E-69E2-4CC7-9274-8198AB486421Q52350385-F020F49F-400E-4AD3-90B9-D3466D2F8E87
P2860
Integrating substance abuse care with community diabetes care: implications for research and clinical practice.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Integrating substance abuse ca ...... esearch and clinical practice.
@ast
Integrating substance abuse ca ...... esearch and clinical practice.
@en
type
label
Integrating substance abuse ca ...... esearch and clinical practice.
@ast
Integrating substance abuse ca ...... esearch and clinical practice.
@en
prefLabel
Integrating substance abuse ca ...... esearch and clinical practice.
@ast
Integrating substance abuse ca ...... esearch and clinical practice.
@en
P2093
P2860
P356
P1476
Integrating substance abuse ca ...... esearch and clinical practice.
@en
P2093
Udi E Ghitza
P2860
P356
10.2147/SAR.S39982
P577
2013-01-11T00:00:00Z